Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma

BACKGROUND: Alpha-l-fucosidase (AFU) not only detects hepatocellular carcinoma (HCC) early but also is used as a clinical prognostic indicator of several malignant tumors. However, no study has investigated the prognostic significance of AFU in a cohort of patients with esophageal squamous cell carc...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Thorac Dis
Main Authors: Yu, Xiangyang, Zhang, Rusi, Yang, Tianzhen, Zhang, Mengqi, Xi, Kexing, Lin, Yongbin, Wen, Yingsheng, Wang, Gongming, Huang, Zirui, Zhang, Xuewen, Zhang, Lanjun
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2019
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790429/
https://ncbi.nlm.nih.gov/pubmed/31656672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.08.92
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares